StockData
Cardiff Oncology, Inc. logo

Cardiff Oncology, Inc. (CRDF) stock

CRDFNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$0.89+0.05 (+6.39%)

Close on Nov 19, 2026Market cap $69.44MP/E –Yield –

Cardiff Oncology EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

No ev/ebitda figures for Cardiff Oncology

Cardiff Oncology has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Cardiff Oncology figures

See a number that looks wrong?